Page last updated at 07:49 GMT, Saturday, 30 August 2008 08:49 UK

Leading Questions: Andrew Witty


GlaxoSmithKline, the world’s second largest pharmaceuticals company, is probably the most important private-sector contributor to science in the UK and is a significant contributor to global developments in healthcare. But it is no longer seen as the great British success it once was.

For this week's Leading Questions, GSK's new chief executive Andrew Witty, in his first major interview, tells the BBC's Business Editor Robert Peston how he intends to win back the confidence both of investors and of customers.

Story Tools


Sign in

BBC navigation

Copyright © 2019 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.

Americas Africa Europe Middle East South Asia Asia Pacific